ZimVie Inc. involved in the Dental and Spine markets which develops, manufactures and delivers a portfolio of products and solutions designed to treat Spine pathologies and support Dental tooth replacement and restoration procedures. ZimVie Inc. is headquartered in Westminster, Colorado.
Revenue (Most Recent Fiscal Year) | $449.75M |
Net Income (Most Recent Fiscal Year) | $-25.83M |
PE Ratio (Current Year Earnings Estimate) | -- |
PE Ratio (Trailing 12 Months) | 11.35 |
PEG Ratio (Long Term Growth Estimate) | -- |
Price to Sales Ratio (Trailing 12 Months) | 0.56 |
Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 0.63 |
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 4.83 |
Pre-Tax Margin (Trailing 12 Months) | -3.55% |
Net Margin (Trailing 12 Months) | -4.40% |
Return on Equity (Trailing 12 Months) | 5.53% |
Return on Assets (Trailing 12 Months) | 2.84% |
Current Ratio (Most Recent Fiscal Quarter) | 2.14 |
Quick Ratio (Most Recent Fiscal Quarter) | 1.48 |
Debt to Common Equity (Most Recent Fiscal Quarter) | 0.58 |
Inventory Turnover (Trailing 12 Months) | 2.07 |
Book Value per Share (Most Recent Fiscal Quarter) | $14.19 |
Earnings per Share (Most Recent Fiscal Quarter) | $0.27 |
Earnings per Share (Most Recent Fiscal Year) | $0.62 |
Diluted Earnings per Share (Trailing 12 Months) | $-0.71 |
Exchange | NASDAQ |
Sector | Healthcare |
Industry | Medical Devices |
Common Shares Outstanding | 27.85M |
Free Float | 27.01M |
Market Capitalization | $249.79M |
Average Volume (Last 20 Days) | 0.18M |
Beta (Past 60 Months) | 2.16 |
Percentage Held By Insiders (Latest Annual Proxy Report) | 3.01% |
Percentage Held By Institutions (Latest 13F Reports) | 95.63% |
Annual Dividend (Based on Last Quarter) | $0.00 |
Dividend Yield (Based on Last Quarter) | 0.00% |